| Identification | Back Directory | [Name]
BENEXATE HYDROCHLORIDE | [CAS]
78718-25-9 | [Synonyms]
TKG 01
C13182
BENEXATE HCL
BENEXATE HYDROCHLORIDE
(4β-(Guanidinomethyl)-1α-cyclohexanecarboxylic acid o-(benzyloxycarbonyl)phenyl)·hydrochloride
2-[[[4α-(Guanidinomethyl)cyclohexane-1β-yl]carbonyl]oxy]benzoic acid phenylmethyl·hydrochloride
Benzoic acid, 2-[[[trans-4-[[(aminoiminomethyl)amino]methyl]cyclohexyl]carbonyl]oxy]-, phenylmethyl ester, monohydrochloride
Benzoic acid, 2-[[[4-[[(aminoiminomethyl)amino]methyl]cyclohexyl]carbonyl]oxy]-, phenylmethyl ester, monohydrochloride, trans- | [Molecular Formula]
C23H27N3O4.ClH | [MOL File]
78718-25-9.mol | [Molecular Weight]
445.944 |
| Hazard Information | Back Directory | [Description]
Benexate hydrochloride is a cytoprotective agent useful in the treatment of ulcers. In
experimental models benexate inhibits the decrease of PGE2 and PGI2 induced by
indomethacin or stress. Its relatively long duration of action offers a distinct advantage
over other cytoprotective drugs. | [Originator]
Teikoku Chemical (Japan) | [Definition]
ChEBI: Benexate hydrochloride is an organic molecular entity. | [Brand name]
Lonmiel; Ulgut |
|
|